Ms. Elmarie Davoren, Principal Investigator at the National Metabolomics Platform (NMP), was recently chosen as one of a select few to attend a 5-day course on quantitative metabolite measurement for clinical metabolomics at The Metabolomics Innovation Centre (TMIC) in Canada. This was also the first time that this course was presented by TMIC in collaboration with The Association for Mass Spectrometry & Advances in the Clinical Lab (MSACL).
The course, led by acclaimed metabolomics expert Dr. David Wishart and his team, provided an intensive blend of hands-on training, expert lectures, and access to state-of-the-art instrumentation. This rigorous programme is designed for those who are deeply involved in the field of metabolomics, ensuring that participants gain the most current and relevant knowledge available.
Upon receiving the invitation, Ms. Davoren expressed her enthusiasm, noting, “I was absolutely thrilled and honoured to receive the invitation. I knew that the knowledge and skills gained would significantly enhance my professional capabilities and contribute to my career development goals.” Her excitement reflects the high calibre of this training and its anticipated benefits.
The focus of the course was on the robust and absolute quantitation of chemicals through mass spectrometry, with a particular emphasis on quantitative MS-based assays. Ms. Davoren found the practical sessions to be particularly beneficial, stating, “The opportunity to directly apply what we learned to real-world experiments was highly rewarding. I particularly appreciated learning how they implement ISO-level quantitative metabolite measurement assays in metabolomics research, given my background in adhering to ISO15189 standards in a clinical setting.” This hands-on experience provided invaluable insights into advanced techniques and their practical applications.
The skills and knowledge gained from this course are expected to have a significant impact on the NMP’s capabilities. Ms. Davoren plans to leverage her new expertise to enhance the platform’s contract research services, focusing on developing robust experimental protocols and ensuring stringent quality control. She anticipates that these advancements will enable her to tackle more complex projects and contribute to expanding the NMP’s overall capabilities.
In addition to the technical training, the course offered excellent networking opportunities. Ms. Davoren interacted with professionals from various backgrounds and institutions, including the chance to engage directly with Dr. David Wishart. These interactions are anticipated to foster potential collaborations and keep the NMP at the forefront of current trends in the field.
Looking forward, Ms. Davoren is inspired to develop and implement cutting-edge quantitative assays for a broader range of metabolites. She also aims to enhance the NMP’s research and diagnostic capabilities, particularly in clinical-grade targeted metabolomics. This forward-looking approach underscores her commitment to advancing the field and the NMP’s role in it.
To ensure that the knowledge gained is disseminated throughout the NMP team, Ms. Davoren will be organising hands-on training sessions and creating comprehensive documentation and protocols. “By doing this, I hope to foster a culture of knowledge sharing and continuous improvement within our institution,” she explained. This initiative is expected to further enhance the team’s skills and drive collective growth.
The National Metabolomics Platform is proud of Ms. Elmarie Davoren’s achievement and eagerly anticipates the positive impact her enhanced expertise will bring to its research capabilities and services.
